120 related articles for article (PubMed ID: 3327449)
1. Immunofluorescent studies of the anti-microtubule effects of the anti-cancer drug estramustine.
Wang M; Tew KD; Stearns ME
Anticancer Res; 1987; 7(6):1165-71. PubMed ID: 3327449
[TBL] [Abstract][Full Text] [Related]
2. The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells.
Sheridan VR; Speicher LA; Tew KD
Eur J Cell Biol; 1991 Apr; 54(2):268-76. PubMed ID: 1879438
[TBL] [Abstract][Full Text] [Related]
3. Antiinvasive activity of estramustine on malignant MO4 mouse cells and on DU-145 human prostate carcinoma cells in vitro.
Mareel MM; Storme GA; Dragonetti CH; De Bruyne GK; Hartley-Asp B; Segers JL; Rabaey ML
Cancer Res; 1988 Apr; 48(7):1842-9. PubMed ID: 3349462
[TBL] [Abstract][Full Text] [Related]
4. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
Speicher LA; Barone L; Tew KD
Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
[TBL] [Abstract][Full Text] [Related]
5. Antimicrotubule effects of estramustine, an antiprostatic tumor drug.
Stearns ME; Tew KD
Cancer Res; 1985 Aug; 45(8):3891-7. PubMed ID: 4016756
[TBL] [Abstract][Full Text] [Related]
6. Estramustine depolymerizes microtubules by binding to tubulin.
Dahllöf B; Billström A; Cabral F; Hartley-Asp B
Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
[TBL] [Abstract][Full Text] [Related]
7. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
Stearns ME; Wang M; Tew KD; Binder LI
J Cell Biol; 1988 Dec; 107(6 Pt 2):2647-56. PubMed ID: 3060470
[TBL] [Abstract][Full Text] [Related]
8. Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve.
Kanje M; Deinum J; Wallin M; Ekström P; Edström A; Hartley-Asp B
Cancer Res; 1985 May; 45(5):2234-9. PubMed ID: 2580617
[TBL] [Abstract][Full Text] [Related]
9. Mechanism based chemotherapy for prostate cancer.
Sheridan VR; Tew KD
Cancer Surv; 1991; 11():239-54. PubMed ID: 1841754
[TBL] [Abstract][Full Text] [Related]
10. Estramustine induces disorganization of microtubules, perinuclear retraction of vimentin and endoplasmatic reticulum, and inhibits cell migration.
Rutberg M; Wallin M
Acta Histochem; 1993 Dec; 95(2):155-67. PubMed ID: 8135088
[TBL] [Abstract][Full Text] [Related]
11. Effects of estramustine and its constituents on human malignant glioma cells.
von Schoultz E; Lundgren E; Henriksson R
Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
[TBL] [Abstract][Full Text] [Related]
12. Intracellular effects of estramustine (Estracyt/Emcyt).
Tew KD; Stearns ME
Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
[No Abstract] [Full Text] [Related]
13. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
Wong AL; McGeorge A; Abel BJ
Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
[No Abstract] [Full Text] [Related]
14. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
15. Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustine.
Tew KD; Stearns ME
Urol Res; 1987; 15(3):155-60. PubMed ID: 3307087
[TBL] [Abstract][Full Text] [Related]
16. Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine.
Tew KD; Woodworth A; Stearns ME
Cancer Treat Rep; 1986 Jun; 70(6):715-20. PubMed ID: 3731136
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
Trykker HU
Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
[No Abstract] [Full Text] [Related]
18. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Ranganathan S; McCauley RA; Dexter DW; Hudes GR
Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
Stridsklev IC; Fosså SD; Kaalhus O
Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
[No Abstract] [Full Text] [Related]
20. Growth of prostatic cancer cells, DU 145, as multicellular spheroids and effects of estramustine.
Essand M; Nilsson S; Carlsson J
Anticancer Res; 1993; 13(5A):1261-8. PubMed ID: 8239495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
